en

PRODUCT DETAIL

Spiromon 4 mg žuvacie tablety

Code 20357
MA number 14/0346/10-S
Product Form: tbl mnd 56x4 mg (blis.nylon/Alu/PVC)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 14 - BRONCHODILATANTIA, ANTIASTHMATICA
ATC:
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DC Leukotriene receptor antagonists
R03DC03 Montelukast
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 15.06.2010
Pediatric indication: Yes
Pediatric posology: Yes
SPC: SPC_Spiromon 4 mg_06.2021.pdf  
PIL: PIL_Spiromon 4 mg_06.2021.pdf  
Safety feature Yes
Data update: 05.06.2018
eu-flag.png sk-flag.png